Business Context and Reporting Period
This Form 8-K Current Report was filed by American Shared Hospital Services (AMS) on March 13, 2026. The filing discloses the entry into a material definitive agreement regarding a proton beam radiation therapy system leased to Orlando Health, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on the terms of a lease amendment rather than periodic financial performance.
Material Changes
The primary material change is the execution of Amendment Two to the Proton Beam Radiation Therapy Lease Agreement with Orlando Health, Inc. Key modifications include:
- Term Extension: The lease term is extended for seven years, running from April 6, 2026, through April 5, 2033.
- Payment Structure: Lease payments during the extended term are based on a technical component collection percentage, which is scheduled to decrease during certain 12-month periods within the term.
- Purchase Option: Orlando Health is granted an option to purchase the leased equipment at the end of the lease term, with specific pricing and exercise periods defined in the agreement.
- End-of-Term Obligations: The agreement outlines the Company's obligation to remove the equipment at its own expense if the purchase option is not exercised, along with related financial understandings.
- Maintenance and Insurance: Updated obligations regarding maintenance and insurance coverage for the parties are established.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future financial performance, or a discussion of general risks. The document notes that certain portions of the attached exhibit have been omitted as they are considered competitively harmful or confidential. The primary contingency noted is the potential exercise of the purchase option by Orlando Health at the end of the extended term.
Investor Verification Checklist
- Review the full text of Exhibit 10.1 (Amendment Two) to understand the specific calculation methodology for the decreasing technical component collection percentage.
- Verify the specific purchase price and the exact window for Orlando Health to exercise the purchase option, as these details are referenced but not explicitly stated in the summary text.
- Assess the financial impact of the Company's obligation to remove the equipment at its expense if the purchase option is declined.
- Confirm the impact of the seven-year extension on the Company's long-term revenue visibility and asset utilization.